Abstract: Compositions which comprise a hydro-phobic taxane such as paclitaxel are produced by non-covalent complexing between the taxane and alpha-fetoprotein c at a ratio of about 4 moles of taxane per mole of AFP. The complexes are water soluble and suitable for injection. Uses of the compositions for treating a subject presenting with an AFP receptor positive and taxane responsive ease cell are also disclosed.

Abstract: The invention discloses a new class of compounds, namely fluorescently labelled bile acids, as well as processes for their production. These compounds may be used for diagonistic and research purposes in humans and animals. The fluorescently labelled bile acids may be used: to indirectly measure hepatic blood flow; to measure gastrointestinal absorption of bile acids or salts; for the localization of nodules in tissues which absorb bile acids; and for the in vitro and in-vivo analysis of cellular or microcirculatory transport or other phenomena.